Literature DB >> 7781921

The mechanism of acute hypoxic pulmonary vasoconstriction: the tale of two channels.

E K Weir1, S L Archer.   

Abstract

Hypoxia causes constriction in small pulmonary arteries and dilatation in systemic arteries. Hypoxic pulmonary vasoconstriction (HPV) is an important mechanism by which pulmonary blood flow is controlled in the fetus and by which local lung perfusion is matched to ventilation in the adult. HPV reduces the flow of desaturated blood through underventilated areas of lung. Even though many vasoactive substances have been examined as possible mediators of HPV, these appear more likely to be modulators than mediators. Hypoxic contraction has been demonstrated in single pulmonary vascular smooth muscle cells (PVSMC). The ability to sense changes in oxygen tension is observed in PVSMC and type 1 cells of the carotid body. In both cells, hypoxia has been shown to inhibit an outward potassium current, thus causing membrane depolarization and calcium entry through the voltage-dependent calcium channels. In both cells there is evidence to suggest that changes in the redox status of the oxygen-sensitive potassium channel or channels may control current flow, so that the channel is open when oxidized and closed when reduced. The redox status may be determined by the effects of hypoxia on mitochondrial/peroxisomal function or on the activity of an oxidase similar to NAD(P)H oxidase. More studies are needed to precisely define the individual potassium channels responsive to hypoxia and to confirm the gating mechanism. In systemic arteries hypoxia causes an increased current through ATP-dependent potassium channels and vasodilatation, whereas in the pulmonary arteries hypoxia inhibits potassium current and causes vasoconstriction.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7781921     DOI: 10.1096/fasebj.9.2.7781921

Source DB:  PubMed          Journal:  FASEB J        ISSN: 0892-6638            Impact factor:   5.191


  84 in total

Review 1.  Cellular responses to hypoxia in the pulmonary circulation.

Authors:  S O Brij; A J Peacock
Journal:  Thorax       Date:  1998-12       Impact factor: 9.139

Review 2.  5-hydroxytryptamine and the pulmonary circulation: receptors, transporters and relevance to pulmonary arterial hypertension.

Authors:  M R MacLean; P Herve; S Eddahibi; S Adnot
Journal:  Br J Pharmacol       Date:  2000-09       Impact factor: 8.739

Review 3.  PAS domains: internal sensors of oxygen, redox potential, and light.

Authors:  B L Taylor; I B Zhulin
Journal:  Microbiol Mol Biol Rev       Date:  1999-06       Impact factor: 11.056

Review 4.  Oxygen sensing in neuroendocrine cells and other cell types: pheochromocytoma (PC12) cells as an experimental model.

Authors:  Zachary Spicer; David E Millhorn
Journal:  Endocr Pathol       Date:  2003       Impact factor: 3.943

5.  Instantaneous restoration of cardiac output by noninvasive positive pressure ventilation in a patient with obesity hypoventilation syndrome.

Authors:  Masayoshi Yoshida; Shin-Ichi Ando; Toshiaki Kadokami; Sumito Narita; Hidetoshi Momii; Yumi Sato; Tomoko Kiyokawa; Chikako Nakao
Journal:  J Cardiol Cases       Date:  2010-12-14

6.  Oxygen-induced constriction of rabbit ductus arteriosus occurs via inhibition of a 4-aminopyridine-, voltage-sensitive potassium channel.

Authors:  M Tristani-Firouzi; H L Reeve; S Tolarova; E K Weir; S L Archer
Journal:  J Clin Invest       Date:  1996-11-01       Impact factor: 14.808

Review 7.  NO: COPD and beyond.

Authors:  A T Jones; T W Evans
Journal:  Thorax       Date:  1997-08       Impact factor: 9.139

8.  Changes in functional and histological distributions of nitric oxide synthase caused by chronic hypoxia in rat small pulmonary arteries.

Authors:  Mikiyasu Shirai; James T Pearson; Akito Shimouchi; Noritoshi Nagaya; Hirotsugu Tsuchimochi; Ishio Ninomiya; Hidezo Mori
Journal:  Br J Pharmacol       Date:  2003-07       Impact factor: 8.739

9.  Hypoxia triggers subcellular compartmental redox signaling in vascular smooth muscle cells.

Authors:  Gregory B Waypa; Jeremy D Marks; Robert Guzy; Paul T Mungai; Jacqueline Schriewer; Danijela Dokic; Paul T Schumacker
Journal:  Circ Res       Date:  2009-12-17       Impact factor: 17.367

10.  Inhibition of 5-lipoxygenase-activating protein (FLAP) reduces pulmonary vascular reactivity and pulmonary hypertension in hypoxic rats.

Authors:  N F Voelkel; R M Tuder; K Wade; M Höper; R A Lepley; J L Goulet; B H Koller; F Fitzpatrick
Journal:  J Clin Invest       Date:  1996-06-01       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.